Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07318428

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma

A Multicenter Clinical Study to Validate the Performance Improvement of Fundus Photography Reading Software

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Inje University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this multi-center study is to evaluate the extent to which AI-assisted fundus image interpretation improves the diagnostic performance of ophthalmologists. Rather than assessing the standalone algorithm performance, this study aims to determine the clinical value of using AI as a decision-support tool within actual clinical workflows. At each participating institution, five ophthalmologists within three years of board certification and five ophthalmology residents will participate as readers. All readers will interpret fundus images both with and without the AI-based assistance software. The study will quantitatively compare diagnostic accuracy and reading time across the two conditions for four posterior segment diseases: diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma.

Conditions

Interventions

TypeNameDescription
DEVICEVUNO Med-Fundus AIThe intervention consists of an AI-based fundus image interpretation software that provides automated outputs for 12 retinal and optic nerve findings (e.g., hemorrhage, exudates, drusen, optic disc change). The system does not generate a direct disease diagnosis. Instead, the AI displays the presence or absence of 12 predefined findings along with their lesion locations. Readers may use this finding-level information as decision-support when determining the presence of the four target diseases (diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma).

Timeline

Start date
2026-02-20
Primary completion
2026-04-30
Completion
2026-05-30
First posted
2026-01-06
Last updated
2026-03-11

Locations

5 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07318428. Inclusion in this directory is not an endorsement.